InvestorsHub Logo
Followers 188
Posts 22497
Boards Moderated 0
Alias Born 08/14/2011

Re: 81vette post# 52

Friday, 06/09/2023 7:27:11 AM

Friday, June 09, 2023 7:27:11 AM

Post# of 82
ADC Therapeutics Announces Updated LOTIS-2 Results Demonstrating Durable, Long-Term Responses of ZYNLONTA® in Relapsed/Refractory DLBCL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADCT News